Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure‐safety relationship in patients with non–small cell lung cancer

JF Lu, SM Eppler, J Wolf, M Hamilton… - Clinical …, 2006 - Wiley Online Library
Objective Our objective was to assess the pharmacokinetics of erlotinib in a large patient
population with solid tumors, identify covariates, and explore relationships between …
被引用次数：255 相关文章

Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non-small cell lung cancer

JF Lu, SM Eppler, J Wolf, M Hamilton… - Clinical …, 2006 - pubmed.ncbi.nlm.nih.gov
Objective Our objective was to assess the pharmacokinetics of erlotinib in a large patient
population with solid tumors, identify covariates, and explore relationships between …

[引用][C] Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non–small cell lung cancer

J LU, S EPPLER, J WOLF, M HAMILTON… - Clinical Pharmacology …, 2006 - cir.nii.ac.jp
Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety
relationship in patients with non–small cell lung cancer | CiNii Research CiNii 国立情報学 …

Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non-small cell lung cancer.

JF Lu, SM Eppler, J Wolf, M Hamilton… - Clinical …, 2006 - europepmc.org
Objective Our objective was to assess the pharmacokinetics of erlotinib in a large patient
population with solid tumors, identify covariates, and explore relationships between …

Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non–small cell lung cancer

JF Lu, SM Eppler, J Wolf, M Hamilton, A Rakhit… - Clinical Pharmacology & …, 2006 - infona.pl
Our objective was to assess the pharmacokinetics of erlotinib in a large patient population
with solid tumors, identify covariates, and explore relationships between exposure and …

[引用][C] Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non-small cell lung cancer

JF LU, SM EPPLER, J WOLF… - Clinical …, 2006 - pascal-francis.inist.fr
Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety
relationship in patients with non-small cell lung cancer CNRS Inist Pascal-Francis CNRS …

[引用][C] Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non-small cell lung cancer

JF LU, SM EPPLER, J WOLF… - Clinical …, 2006 - Nature Publishing Group